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Background: Caffeine is one of the most frequently ingested (at various tempe-
ratures) xenobiotics by people. A number of studies have confirmed the negative 
effect of high doses of caffeine ingested during pregnancy both for the mother 
and the developing foetus. The aim of this study was to evaluate the relation-
ship between caffeine’s toxicity on development and the administered solution’s 
temperature. 
Materials and methods: The research was conducted on rats. The fertilised 
females were randomly divided into two main groups: an experimental (E) and 
a control group (C). The experimental groups received caffeine (30 mg/day) in 
10 (E1), 25 (E2) and 45°C (E3). The females in the control group were given water 
at the same temperature (C1, C2 and C3). On the 21
st day of pregnancy, the pre-
gnant females were killed by decapitation using a specially prepared laboratory 
guillotine and were assessed morphometric parameters of foetuses. 
Results and Conclusions: Based on this work showed that: the embryotoxic 
effect of caffeine was only confined to a reduction in the number of offspring; 
the greatest changes in the morphometric parameters occurred in foetuses whose 
mothers received caffeine at 10°C; in the control groups, the greatest changes 
were observed in foetuses whose mothers were given water at 10°C during pre-
gnancy. (Folia Morphol 2014; 72, 3: 347–352)
Key words: caffeine, morphometric parameters, pregnancy, foetus, 
resorbed foetuses, post-implantation mortality
INTRODUCTION
Caffeine is widespread throughout nature. In its 
processed form it is one of the most frequently in-
gested xenobiotics by people, including pregnant 
women. Some of the xenobiotics are routinely con-
sumed chilled (Cola®, Red Bull®), at room temperature 
(chocolate, sweets), or hot (coffee, tea).
Caffeine is quickly and completely absorbed from 
the gastrointestinal tract, and is metabolised mainly 
in the liver (cytochrome P450). Its metabolism de-
pends on gender, age, the organism’s physiological 
state, oral contraceptives and smoking. In addition 
to the organism’s ontogenic characteristics caffeine’s 
pharmacokinetics are also affected by the time of day 
of its consumption [26]. A number of studies have 
shown that caffeine easily passes through biological 
membranes, including the blood-brain barrier, the 
placental barrier and can also enter the amniotic fluid, 
breast milk and semen [12, 19, 23, 39].
From the time when Nishimura and Nakai [24] 
demonstrated the adverse effect of caffeine on mice 
offspring, this substance became the focus of inter-
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est for teratologists. Since then, a number of studies 
have confirmed the negative effect of high doses 
of caffeine ingested during pregnancy both for the 
mother and the developing foetus [2, 3, 7, 15, 16, 
18, 22, 25, 27, 30, 31].
Despite extensive literature on the toxicity of 
methylxanthine, there are no reports evaluating the 
effects of caffeine on foetal development, with re-
spect to temperature.
The aim of this study was to evaluate the relation-
ship between caffeine’s toxicity on development and 
the administered solution’s temperature.
MaTeRIals aND MeThODs
The research was based on an animal experimental 
model, according to international guidelines for the 
assessment of developmental toxicity [5, 36], with 
the consent of the Ethics Committee at the Medical 
University of Lublin.
The research was conducted on white rats of the 
Wistar strain CRL: (WI) WUBR. All animals were in fixed 
environmental conditions with access to water and 
feed [13, 35] being freely available. Only standardised 
pelleted LSM® feed was used. Feed and water con-
sumption was monitored on a daily basis.
After a 2 week acclimatisation period, the virgin 
females with a body mass (238 ± 24 g) mated over-
night with males (from 8 pm to 8 am) in a ratio of 
5:2. The presence of spermatozoa or a clot containing 
a mixture of semen and exfoliated vaginal epithelial 
in the morning vaginal swab was proof of success-
ful copulation. The fertilised females were randomly 
divided into three experimental groups (E1, E2, and E3) 
and three control groups (C1, C2, and C3) each consist-
ing of 8 rats. The day of fertilisation was considered 
to be the first day of pregnancy.
The study used caffeine (Caffeine anhydrous po-
wder, Sigma-Aldrich Chemie GmbH, Germany) with 
a purity exceeding 99%, administered in a dose of 
30 mg/day, which according to the data in the literature 
should interfere with the rat’s prenatal development 
[1, 4, 20].
The caffeine was dissolved in sterile distilled water 
at temperatures of 10°C (E1), 25°C (E2) and 45°C (E3) 
and a single daily dose of 2 mL/kg body mass was 
administered intragastrically to the females from the 
8th to the 21st day of pregnancy. The females in the 
control groups (C1, C2 and C3) received the same 
amount of water at the same temperature as the 
ones in the experimental groups (E1, E2 and E3). Du-
ring the study the females’ body mass was recorded 
every three days.
On the 21st day of pregnancy, the pregnant fe-
males were killed by decapitation using a specially 
prepared laboratory guillotine. Death was caused by 
breaking the continuity of the spinal cord without 
damaging the continuity of the external layers.
After cutting the covering tissues of the abdomi-
nal cavity, the uterus with the foetuses were incised. 
The numbers of live, dead, and resorbed foetuses 
were counted. The post-implantation mortality rate 
(S) was calculated as follows:
where: z — number of implantations; n — number 
of live foetuses.
After incising the placentas and the foetal memb-
ranes, foetal vitality was assessed. A foetus which did 
not breathe, was motionless, did not react or its skin 
did not redden when touched was classified as dead.
The placentas were incised from the foetal memb-
rane and the umbilical cord and were evaluated mac-
roscopically, and then their mass was determined.
The foetuses were put to sleep using liquid ni-
trogen vapour, weighed and the crown rump length 
(which is considered to be the length of the foetus) 
as well as the maximum width of the head were 
measured [2]. The body mass index (BMI) was also 
calculated:
where: m — weight of the foetus; l — length of the 
foetus.
Statistical analysis
The Shapiro-Wilk test was used to test the norma-
lity of distribution for other group characteristics. For 
parameters with a normal distribution the analysis 
of variance (ANOVA) was used, however, where this 
condition was not met the Kruskal-Wallis test was 
performed.
For statistical analysis the STATISTICA 7.0 (Stat-
Soft Inc., USA) computer program was used. For all 
the tests the statistically significant differences were 
those, where the significance coefficient (p) was less 
than 0.05.
100% ×−=
z
nzS
2l
mBMI =
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ResUlTs
In the population of rats taking part in the study 
(in both the control and experimental groups) no 
females died during the study. There were no signi-
ficant differences in the amount of feed and water 
consumed between the groups.
Table 1 shows the average weight gain of the 
female rats during pregnancy. Statistically significant 
differences in weight gain were already observed 
from the 6th day of gestation, both in the control 
and in the experimental groups. The greatest weight 
gains were found in the control group which was 
given water at 25°C; these changes were statistically 
significant in relation to the control animals which 
were administered water at 45°C. In the experimen-
tal groups the greatest weight gains were observed 
in females receiving caffeine also at 25°C. However, 
these differences were statistically significant for ani-
mals which were administered caffeine at both 10°C 
or 45°C. It should be emphasised that there were no 
significant differences in weight gains among females 
between the experimental groups (E1, E2 and E3) and 
their respective control groups.
The resorption count in individual litters was va-
riable and ranged from 0 to 2 (Table 2), but these 
differences were not statistically significant. In ad-
dition, the post-implantation mortality rate did not 
differ significantly between the groups and ranged 
from 0 to 2.82 (Table 2).
The weight of the placenta (Table 2) was signifi-
cantly lower in the females from the control group 
receiving water at 45°C as compared to other control 
Table 1. Average weight gain in pregnant female sin the experimental (E1, E2, E3) and control (C1,C2, C3) groups
Day of  
pregnancy
Group of animals The significance  
of differences  
between groupsC1 E1 C2 E2 C3 E3
3 12.63 ± 6.50 6.75 ± 3.06 13.25 ± 5.87 14.56 ± 8.58 7.75 ± 2.75 9.29 ± 5.76 P < 0.05 
E1 vs. E2
6 24.25 ± 8.14 15.50 ± 6.97 26.60 ± 5.29 25.33 ± 10.22 19.50 ± 3.00 20.86 ± 7.01 P < 0.05 
C1 vs. E1, C1 vs. C2, 
C2 vs. C3, E1 vs. E2
9 37.75 ± 7.94 24.38 ± 11.31 44.63 ± 8.65 39.11 ± 15.09 26.75 ± 6.45 32.00 ± 9.29 P < 0.05 
C1 vs. E1, C1 vs. C2, 
C2 vs. C3, E1 vs. E2
12 50.63 ± 9.25 37.38 ± 18.65 61.63 ± 9.62 53.30 ± 19.42 36.75 ± 12.89 39.57 ± 12.68 P < 0.05 
C2 vs. C3, E1 vs. E2
15 60.13 ± 10.42 61.13 ± 44.53 77.38 ± 8.45 71.11 ± 24.06 46.75 ± 20.37 50.00 ± 12.68 P < 0.05 
C2 vs. C3, E1 vs. E2
18 71.38 ± 12.48 58.50 ± 29.37 99.13 ± 8.75 90.70 ± 28.05 58.00 ± 25.52 62.57 ± 20.76 P < 0.05 
C2 vs. C3, E1 vs. E2,  
E2 vs. E3
21 83.75 ± 14.72 64.88 ± 31.06 123.38 ± 14.85 111.82 ± 31.32 74.00 ± 40.702 74.71 ± 26.72 P < 0.05 
C2 vs. C3, E1 vs. E2
Table 2. The number of resorbed foetuses, post-implantation mortality and the weight of placenta in groups exposed to caffeine  
(E1, E2, E3) and control groups (C1,C2, C3)
Group of animals The significance  
of differences  
between groupsC1 E1 C2 E2 C3 E3
Number of resorbed foetuses 0.92 ± 0.63 0.71 ± 0.25 0.35 ± 0.13 0.46 ± 0.25 0.87 ± 0.75 0.76 ± 0.50 NS
Post-implantation mortality 1.21 ± 0.82 0.72 ± 0.26 0.34 ± 0.12 0.43 ± 0.23 1.25 ± 1.06 1.01 ± 0.67 NS
Weight of placenta [g] 0.59 ± 0.26 0.31 ± 0.14 0.59 ± 0.09 0.43 ± 0.07 0.38 ± 0.17 0.43 ± 0.12 P < 0.05
NS — insignificant statistically (p > 0.05)
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groups. Significant differences were also found be-
tween the groups in which females received water 
or caffeine at 10°C. Asymmetric placental fusion was 
observed in only 1 case, in a litter exposed to caffeine 
at 25°C. Apart from this, no other macroscopically 
visible abnormalities were observed.
In the studied rat offspring population, the smal-
lest number of foetuses were found in the groups 
which were administered water or caffeine at 45°C. 
These changes were significant compared to animals 
receiving water at 25°C. However, there were no signi-
ficant differences in the number of foetuses between 
the experimental groups and the corresponding con-
trol groups (Table 3).
The greatest foetal weights in the experimental 
and control groups occurred in those groups where 
the pregnant females received water or caffeine at 
25°C (Table 3) whilst the lowest in those groups which 
received caffeine at 10°C or 45°C. These differen-
ces were statistically significant in both the C2 and 
E2 groups. Significant differences in foetal weights were 
also observed between the control groups, in which the 
females received water at 25°C or 45°C (Table 3).
The longest body lengths were observed in foetuses 
whose mothers received water or caffeine at 25°C, and 
the shortest in those groups, in which the females 
were given caffeine at either 10°C or 45°C (Table 3). 
These changes were statistically significant for both the 
control group C2, as well as for the experimental group E2. 
Significant changes in foetal body length between 
control groups C2 and C3 were also observed, as well 
as between the control group and the experimental 
group receiving water or caffeine at 10°C.
The maximum head widths (Table 3) were observed 
in foetuses whose mothers received water or caffeine 
at 25°C. Significant differences were observed between 
the experimental group E2, and the remaining two 
groups, in which the females were given caffeine at 
either 10°C or 45°C. Statistically significant differences 
were also found between the control groups, in which 
water was given at 25°C or 45°C, as well as between 
the group receiving caffeine at 10°C, compared to the 
appropriate control group (C1).
Table 3 shows the average foetal BMI values for 
each group of rats. The highest BMI values were 
observed in the group of foetuses whose mothers 
received water at 45°C (C3). However, in the re-
maining two control groups (C1 and C2) the BMI 
values were significantly lower. Also, significantly 
lower BMI values were observed in foetuses from 
mothers given caffeine at 25°C or 45°C compared 
to the control group C3.
Table 3. Morphometric parameters of foetuses in groups exposed to caffeine (E1, E2, E3) and control groups (C1, C2, C3)
Morphometric  
parameters  
of foetuses
Group of animals The significance  
of differences  
between groupsC1 E1 C2 E2 C3 E3
Number of  
foetuses  
in the litter
9.87 ± 4.64 12.00 ± 1.07 13.13 ± 1.35 12.37 ± 3.06 8.87 ± 3.27 9.37 ± 3.54 P < 0.05 
C2 vs. C3, C2 vs. E3,  
C3 vs. E2
Foetal  
weights [g]
3.91 ± 2.45 2.43 ± 1.66 4.99 ± 0.94 4.65 ± 1.14 3.31 ± 1.34 2.43  ± 0.92 P < 0.05 
C2 vs. C3, C2 vs. E1,  
C2 vs. E3, E1 vs. E2,  
E2 vs. E3
Body  
lengths [mm]
33.36 ± 7.14 23.53 ± 10.42 36.45 ± 2.23 35.08 ± 3.90 25.54 ± 9.64 26.59 ± 4.03 P < 0.05 
C1 vs. C3, C1 vs. E1,  
E1 vs C2, E1 vs. E2,  
C2 vs. C3, C2 vs. E3,  
E2 vs. E3, E2 vs. C3
Head  
widths [mm]
7.73 ± 1.91 5.63 ± 2.71 8.61 ± 0.47 9.00 ± 0.99 6.05 ± 2.52 6.75 ± 1.28 P < 0.05 
C1 vs. E1, E1 vs. C2,  
E1 vs. E2, C2 vs. C3,  
E2 vs. E3, E2 vs. C3
Foetal body  
mass index  
[kg/m2]
3.13 ± 0.93 5.26 ± 2.96 3.72 ± 0.24 3.67 ± 0.46 7.07 ± 4.73 3.29 ± 0.34 P < 0.05 
C1 vs. C3, C2 vs. C3, 
 E2 vs. C3, E3 vs. C3
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DIsCUssION
Caffeine is a compound which passes through the 
placental barrier. Experimental research has shown 
that in high doses it can cause an embryotoxic ef-
fect. In smaller doses it reduces the weight gain of 
pregnant females, reduces the number of offspring 
per litter as well as foetal morphometric parameters 
(it interferes with intrauterine growth) [4, 20, 21, 
28, 29, 34, 37].
Elmazar et al. [4], by giving mice caffeine in doses 
of 150 mg/kg and 250 mg/kg in drinking water and in 
doses of 50 mg/kg and 150 mg/kg in feed, between the 
5th and 18th day of gestation, showed that the increase 
in body weight of females receiving a lower dose of 
caffeine was comparable to the control group, but was 
significantly lower after administering the higher dose. 
The weight of the offspring was significantly lower in 
the group receiving the higher dose of caffeine.
Similar results were also obtained by Smith et al. 
[29], who administered caffeine in doses of 10 mg/kg 
and 100 mg/kg in single or four subdivided doses. 
The weight gain of the pregnant females was lower 
in the groups receiving 100 mg/kg caffeine, irrespec-
tive of whether it was administered as a single dose 
or not, as well as in the group receiving 10 mg/kg 
in subdivided doses. In addition, a reduction in the 
placental weight as well as the number of offspring 
was noted in the groups of animals.
Similar results have been reported by other resear-
chers: West et al. [34] (caffeine administered in doses 
of 50 mg/kg and 75 mg/kg body weight between the 
3rd and 19th day of gestation), Muther [20] (caffeine 
administered in a dose of 100 mg/kg body weight du-
ring pregnancy), Wilkinson and Pollard [37] (caffeine 
administered in a dose of 25 mg/kg on the 8th and 
9th day of gestation) and Nakamoto et al. [21] (caf-
feine administered in dosses between 0.5–2 mg/kg 
between the 8th and 22nd day of gestation). They 
found that caffeine in these doses administered to 
pregnant females results in foetuses being lighter.
Scott [28] administered caffeine intraperitoneally 
to pregnant mice in doses of 80, 100, 150, 175, 200, 
225 and 250 mg/kg. The embryotoxic effect only oc-
curred after the highest caffeine dose. In the group 
of animals receiving intermediate doses, there was 
a slight increase in the foetal resorption rate.
Prenatal studies on Macaca fasciluris monkeys sho-
wed that receiving caffeine during pregnancy reduces 
weight and body length of newborns [8–10]. Female 
rats receiving caffeine in a dose between 10 and 
30 mg/kg had a higher percentage of miscarriages 
and stillborn foetuses. The female body parameters 
were normalised within 30 days, whilst in males, this 
process lasted nearly a year. The offspring of mothers 
receiving caffeine showed behavioural changes — 
they suckled longer and learned more slowly.
It should be emphasised that it is still difficult to 
determine the relationship between caffeine con-
sumption and low birth weight of newborns in pre-
gnant women. This is due to the fact that often 
mothers drinking large quantities of coffee are at the 
same time dependent on tobacco or alcohol — factors 
that also slow down intrauterine development [8]. 
Fortier et al. [6], demonstrated an increased (5.2%) 
risk of giving birth to an underweight baby, if the 
daily intake of caffeine during pregnancy was greater 
than 300 mg/day, compared to a 1.3% risk in mothers 
who did not consume caffeine at all. The difference 
in weight between the two groups of newborns was 
105 g. These findings confirm Watkinson’s and Fried’s 
[32] previous observations. Among the 286 women 
consuming more than 300 mg of caffeine daily during 
pregnancy, babies were born with a lower birth weight.
Infante-Rivard et al. [14] investigated the rela-
tionship between caffeine consumption and sponta-
neous miscarriages among women hospitalised after 
a miscarriage. Consuming caffeine in doses greater 
than 321 mg/day, prior to conception, increased the 
rate of a miscarriage. Caffeine in doses less than 
162 mg/day during pregnancy did not correlate with 
an increased risk of miscarriage.
Other authors have also made similar observa-
tions. Wen et al. [33] showed that the rate of a spon-
taneous miscarriage increased among women who 
consumed caffeine in doses of 300 mg/day and did 
not complain of nausea. In groups of 75 women who 
did not feel nausea, 29.6% had miscarriages whilst 
for women who complained of nausea miscarriages 
only occurred in 7.2% of cases.
CONClUsIONs
Products containing caffeine are consumed in 
a 4–60oC temperature range (Yang et al. 2007 [38]). 
In literatures, there are no reports evaluating the ef-
fects of caffeine on foetal development, with respect 
to temperature. Among the hypotheses supporting 
this relationship, are mentioned different genoty-
pe variants of cytochrome P4501A2 (in people with 
rapid metabolism of caffeine, may constitute a risk 
group for bone loss induced by coffee) (Hallström 
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et al., 2010 [11]) or the presence of new, unknown 
endogenous compounds caffeine (e.g. mono-nitroso-
-caffeidine, an asymmetric di-nitrosamine and caf-
feidine nitroso-N-nitrosamide, which in vitro have 
potential relevance in the aetiology of oesophageal 
and gastric cancers) (Kumar et al., 1992 [17]), which 
deepen the teratogenic effect.
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